EUCTR2022-000434-42-SK进行中（未招募）1 期
A Phase 3b/4 Randomized, Blinded, Treat-to-Target and Dose-Flexibility Study of Upadacitinib in Adult Subjects with Moderate to Severe Atopic Dermatitis (Flex-Up)
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 454
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Male or female subjects =18 and < 65 years of age at the Screening Visit
- •Chronic AD with onset of symptoms at least 3 years prior to Baseline and subject meets Hanifin and Rajka criteria
- •Candidate for systemic treatment
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 454
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Prior exposure to any JAK inhibitor
- •Unable or unwilling to discontinue current AD treatments prior to the study
- •Requirement of prohibited medications during the study treatment
- •Female subject who is pregnant, breastfeeding, or considering pregnancy during the
研究者
相似试验
进行中（未招募）
1 期
This is a study to evaluate dose-flexibility of Upadacitinib in Adult Subjects with Moderate to Severe Atopic DermatitisDermatitis atopicMedDRA version: 20.0Level: PTClassification code: 10012438Term: Dermatitis atopic Class: 100000004858CTIS2023-504869-23-00AbbVie Deutschland GmbH & Co. KG438
尚未招募
4 期
A Phase 3b/4 Randomized, Blinded, Treat-to-Target and Dose-Flexibility Study of Upadacitinib in Adult Subjects with Moderate to Severe Atopic DermatitisAtopic dermatitisNL-OMON53671AbbVie B.V.14
进行中（未招募）
1 期
This is a study to evaluate dose-flexibility of Upadacitinib in Adult Subjects with Moderate to Severe Atopic DermatitisEUCTR2022-000434-42-NLAbbVie Deutschland GmbH & Co. KG454
招募中
4 期
A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic DermatitisAtopic DermatitisJPRN-jRCT2011230021Yamazaki Hayato454
进行中（未招募）
不适用
A Phase 3, Randomized, Single-Blind, Controlled Trial of Topical Fibrocaps™ in Intraoperative Surgical HaemostasisIntraoperative Surgical Hemostasis (Spinal Surgery, Vascular Surgery, Hepatic resection, Soft tissue dissection)MedDRA version: 14.1Level: LLTClassification code 10053001Term: Surgical haemostasisSystem Organ Class: 100000004865EUCTR2011-006174-47-NLProFibrix Inc.672